Cases & Deals

Baxter Ventures invests in Ocular Therapeutix

Clients Baxter International Inc.

Jones Day advised Baxter Ventures in connection with its purchase of Series D-1 Convertible Preferred Stock in a private placement by Ocular Therapeutix, Inc., a developer of ophthalmic therapeutic products through use of its proprietary hydrogel technology.